Intravenous methylprednisolone in the treatment of Graves' ophthalmopathy.

@article{KendallTaylor1988IntravenousMI,
  title={Intravenous methylprednisolone in the treatment of Graves' ophthalmopathy.},
  author={Pat Kendall-Taylor and Aimee L Crombie and Amy M Stephenson and Matthew Hardwick and Kathleen Hall},
  journal={BMJ},
  year={1988},
  volume={297 6663},
  pages={1574-8}
}
Eleven euthyroid patients with severe Graves' eye disease were treated with intravenous methylprednisolone and followed up for six months or more by ophthalmological assessment, orbital computed tomography (CT), photographs, and antibody measurements. Papilloedema resolved in the single patient in whom it was present; visual acuity was abnormal in seven eyes initially and in only one eye after treatment; the intraocular pressure differential, which reflects muscle dysfunction, was initially… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 22 references

Methylprednisolone ill patients with membranous nephropathv and declining renal function

  • CD Short, LR Solomon, R Gokal, ' MallickNP
  • QJ 7 Med
  • 1987

Immuno - logically mediated cytotoxicity against human eve muscle cells in Graves ' ophthalmopathy

  • PW Wang, Y Hiromatsu, L Wosu, J How, Wall
  • J Clin Endocrinol Metab
  • 1986

Similar Papers

Loading similar papers…